Madison-based Merck Animal Health announced it plans to purchase a new manufacturing facility in Austria to expand its global vaccine manufacturing capacity.
The facility, located in Krems an der Donau, is currently owned by Shire plc.
“This new manufacturing site is ideally located in central Europe. It provides MSD Animal Health additional manufacturing resources and advanced technology platforms to meet the growing demand for our vaccine products that prevent disease and keep animals healthy while positioning us for strong long-term growth,” said Joseph Morrissey, senior vice president, operations, MSD Animal Health.
“We are excited to expand our footprint to Krems,” stated Dr. Hans-Günther Dittrich, vice president, Europe, Russia, North Africa, Middle East region. “Krems is the home to several distinct universities, and a rich tradition as an economic center for bio-pharmaceuticals. It is a great opportunity for us to tap into the innovative science in the area.”
Financial terms were not disclosed.